Mylan and Biocon to present phase-III trastuzumab biosimilar data at ASCO annual meeting
HERITAGE study shows comparable efficacy, safety and immunogenicity to branded trastuzumab in HER2-positive metastatic breast…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Mylan
Delhi HC refrains from staying single judge interim order over breast cancer drug by Biocon and…
The division bench of the high court, however, said the drug-makers may continue to sell their products under the brand names
Mylan Health Hackathon to host health hackathon in Bengaluru
The event will focus on better health for a better world
Mylan will host a health hackathon at its Global Center in Bengaluru on…
Mylan acquires certain women healthcare businesses from Famy Care
To create a leading Women's Healthcare Franchise
Govt clears Mylan’s takeover of Jai Pharma
With this approval, FDI of $750 million will be received in the country
The government has approved the proposal of global pharma…
Biocon-Mylan programmes make clinical progress
PEG-G-CSF and Adalimumab enter phase II while patient recruitment for one insulin Glargine phase II study is complete
Biocon has…
Mylan rejects Teva’s $40 bn offer as ‘gross undervaluation’
Says, "bringing Teva's 'dysfunctional' culture to the region (India) could disrupt the core of its business, result in the flight…
Mylan to acquire Famy Care to create women’s healthcare franchise
This transaction especially complements Mylan’s pending acquisition of Abbott’s non-US developed markets speciality and branded…